Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CRISPR/Cas9: at the cutting edge of hepatology.

Gut - 1 Jul 2017

Pankowicz Francis P, Jarrett Kelsey E, Lagor William R, Bissig Karl-Dimiter

Abstract excerpt

Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 genome engineering has revolutionised biomedical science and we are standing on the cusp of medical transformation. The therapeutic potential of this technology is tremendous, however, its translation to the clinic will be challenging. In this article, we review recent progress using this genome editing technology and explore its potential...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clustered Regularly Interspaced Short Palindromic Repeats
Share to CRISPR-Cas Systems

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Editing

Share to Gene Targeting

Share to Gene Transfer Techniques

Share to Genetic Therapy

Share to Hepatitis B virus

Share to Recombinational DNA Repair

Source

Open in PubMed Open full text

Identifiers

PMID: 28487442
DOI: 10.1136/gutjnl-2016-313565
PMCID: PMC5878048

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CRISPR/Cas9: at the cutting edge of hepatology.PMID 28487442Read ↗

CRISPR/Cas9 therapeutics for liver diseases.Semantic proximity Read ↗

In vivo liver targeted genome editing as therapeutic approach: progresses and challengesSemantic proximity Read ↗

Advanced Nanotheranostics of CRISPR/Cas for Viral Hepatitis and Hepatocellular CarcinomaSemantic proximity Read ↗

Emerging and potential use of CRISPR in human liver diseaseSemantic proximity Read ↗

A CRISPR-Cas9 platform for primary human hepatocytes enables arrayed screening and in vivo validation of HBV host factorsSemantic proximity Read ↗

Description of CRISPR/Cas9 development and its prospect in hepatocellular carcinoma treatmentSemantic proximity Read ↗

CRISPR/Cas9 for hepatitis B virus infection treatmentSemantic proximity Read ↗

Potential of CRISPR/Cas system as emerging tools in the detection of viral hepatitis infectionSemantic proximity Read ↗

Advances in precision gene editing for liver fibrosis: From technology to therapeutic applicationsSemantic proximity Read ↗

Research progress and application of the CRISPR/Cas9 gene-editing technology based on hepatocellular carcinomaSemantic proximity Read ↗

CRISPR/Cas and Hepatitis B Therapy: Technological Advances and Practical BarriersSemantic proximity Read ↗

Modeling Non-Alcoholic Fatty Liver Disease (NAFLD) Using "Good-Fit" Genome-Editing Tools.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.